Human Rights Commission grants case against PHARMAC for failing to fund rare muscular disorder drug

Newshub

16 September 2020 - Newshub can reveal a ground-breaking Human Rights Commission case has been taken against Pharmac for failing to fund a drug that treats a rare muscular disorder in children.

It comes as National announced their health policy on Wednesday which would give an extra $5 million a year to the Government's drug-buying agency for funding rare disorder drugs.

National is also pledging to get all elective surgeries done within a four-month timeframe and promising to overhaul the elective surgery points system, making it even across New Zealand in an attempt to put an end to the postcode lottery.

Read Newshub article

Michael Wonder

Posted by:

Michael Wonder